about
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin In East Asian Patients with Stage IV Squamous Non-Small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIREEvaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Necitumumab for non-small cell lung cancer.
@en
type
label
Necitumumab for non-small cell lung cancer.
@en
prefLabel
Necitumumab for non-small cell lung cancer.
@en
P2093
P2860
P1476
Necitumumab for non-small cell lung cancer.
@en
P2093
Fabrice Barlesi
Laurent Greillier
Pascale Tomasini
P2860
P304
P356
10.1517/14712598.2015.1055243
P407
P577
2015-06-08T00:00:00Z